BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 17266043)

  • 21. Ubiquitous induction of resistance to platinum drugs in human ovarian, cervical, germ-cell and lung carcinoma tumor cells overexpressing isoforms 1 and 2 of dihydrodiol dehydrogenase.
    Deng HB; Adikari M; Parekh HK; Simpkins H
    Cancer Chemother Pharmacol; 2004 Oct; 54(4):301-7. PubMed ID: 15138708
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aldo-keto reductase 1C subfamily genes in skin are UV-inducible: possible role in keratinocytes survival.
    Marín YE; Seiberg M; Lin CB
    Exp Dermatol; 2009 Jul; 18(7):611-8. PubMed ID: 19320734
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of human 3α-hydroxysteroid dehydrogenase isoforms (AKR1C1-AKR1C3) in the extrahepatic metabolism of the steroidal aromatase inactivator Formestane.
    Wan R; Kong X; Yang Y; Tao S; Chen Y; Teichmann AT; Wieland FH
    J Steroid Biochem Mol Biol; 2020 Apr; 198():105527. PubMed ID: 31733346
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elevated expression of BIRC6 protein in non-small-cell lung cancers is associated with cancer recurrence and chemoresistance.
    Dong X; Lin D; Low C; Vucic EA; English JC; Yee J; Murray N; Lam WL; Ling V; Lam S; Gout PW; Wang Y
    J Thorac Oncol; 2013 Feb; 8(2):161-70. PubMed ID: 23287853
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of dihydrodiol dehydrogenase plays important roles in apoptosis- and drug-resistance of A431 squamous cell carcinoma.
    Chow KC; Lu MP; Wu MT
    J Dermatol Sci; 2006 Mar; 41(3):205-12. PubMed ID: 16361083
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The SIRT2-mediated deacetylation of AKR1C1 is required for suppressing its pro-metastasis function in Non-Small Cell Lung Cancer.
    Zhu H; Hu Y; Zeng C; Chang L; Ge F; Wang W; Yan F; Zhao Q; Cao J; Ying M; Gu Y; Zheng L; He Q; Yang B
    Theranostics; 2020; 10(5):2188-2200. PubMed ID: 32104503
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic significance of STAT3 expression and its correlation with chemoresistance of non-small cell lung cancer cells.
    Yin Z; Zhang Y; Li Y; Lv T; Liu J; Wang X
    Acta Histochem; 2012 Feb; 114(2):151-8. PubMed ID: 21549414
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interleukin 1β regulates progesterone metabolism in human cervical fibroblasts.
    Roberson AE; Hyatt K; Kenkel C; Hanson K; Myers DA
    Reprod Sci; 2012 Mar; 19(3):271-81. PubMed ID: 22064385
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Difference of growth-inhibitory effect of Scutellaria baicalensis-producing flavonoid wogonin among human cancer cells and normal diploid cell.
    Himeji M; Ohtsuki T; Fukazawa H; Tanaka M; Yazaki S; Ui S; Nishio K; Yamamoto H; Tasaka K; Mimura A
    Cancer Lett; 2007 Jan; 245(1-2):269-74. PubMed ID: 16497434
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-chain fatty acids inhibit human members of the aldo-keto reductase 1C subfamily.
    Hara A; Endo S; Matsunaga T; Soda M; Yashiro K; El-Kabbani O
    J Biochem; 2017 Nov; 162(5):371-379. PubMed ID: 28992312
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanism of progestin resistance in endometrial precancer/cancer through Nrf2-AKR1C1 pathway.
    Wang Y; Wang Y; Zhang Z; Park JY; Guo D; Liao H; Yi X; Zheng Y; Zhang D; Chambers SK; Zheng W
    Oncotarget; 2016 Mar; 7(9):10363-72. PubMed ID: 26824415
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A small molecule pan-Bcl-2 family inhibitor, GX15-070, induces apoptosis and enhances cisplatin-induced apoptosis in non-small cell lung cancer cells.
    Li J; Viallet J; Haura EB
    Cancer Chemother Pharmacol; 2008 Mar; 61(3):525-34. PubMed ID: 17505826
    [TBL] [Abstract][Full Text] [Related]  

  • 33. AKR1C1/2 inhibition by MPA sensitizes platinum resistant ovarian cancer towards carboplatin.
    Badmann S; Mayr D; Schmoeckel E; Hester A; Buschmann C; Beyer S; Kolben T; Kraus F; Chelariu-Raicu A; Burges A; Mahner S; Jeschke U; Trillsch F; Czogalla B
    Sci Rep; 2022 Feb; 12(1):1862. PubMed ID: 35115586
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overexpression of dihydrodiol dehydrogenase as a prognostic marker of non-small cell lung cancer.
    Hsu NY; Ho HC; Chow KC; Lin TY; Shih CS; Wang LS; Tsai CM
    Cancer Res; 2001 Mar; 61(6):2727-31. PubMed ID: 11289154
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chrysin enhances sensitivity of BEL-7402/ADM cells to doxorubicin by suppressing PI3K/Akt/Nrf2 and ERK/Nrf2 pathway.
    Gao AM; Ke ZP; Shi F; Sun GC; Chen H
    Chem Biol Interact; 2013 Oct; 206(1):100-8. PubMed ID: 23994249
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proteomics-based identification of secreted protein dihydrodiol dehydrogenase 2 as a potential biomarker for predicting cisplatin efficacy in advanced NSCLC patients.
    Kuang P; Zhou C; Li X; Ren S; Li B; Wang Y; Li J; Tang L; Zhang J; Zhao Y
    Lung Cancer; 2012 Aug; 77(2):427-32. PubMed ID: 22534668
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Major differences exist in the function and tissue-specific expression of human aflatoxin B1 aldehyde reductase and the principal human aldo-keto reductase AKR1 family members.
    O'connor T; Ireland LS; Harrison DJ; Hayes JD
    Biochem J; 1999 Oct; 343 Pt 2(Pt 2):487-504. PubMed ID: 10510318
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular docking simulations of steroid substrates into human cytosolic hydroxysteroid dehydrogenases (AKR1C1 and AKR1C2): insights into positional and stereochemical preferences.
    Jin Y; Penning TM
    Steroids; 2006 May; 71(5):380-91. PubMed ID: 16455123
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overexpression of aldo-keto reductase 1C2 as a high-risk factor in bladder cancer.
    Tai HL; Lin TS; Huang HH; Lin TY; Chou MC; Chiou SH; Chow KC
    Oncol Rep; 2007 Feb; 17(2):305-11. PubMed ID: 17203165
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction of 1C aldoketoreductases and other drug dose-dependent genes upon acquisition of anthracycline resistance.
    Veitch ZW; Guo B; Hembruff SL; Bewick AJ; Heibein AD; Eng J; Cull S; Maclean DA; Parissenti AM
    Pharmacogenet Genomics; 2009 Jun; 19(6):477-88. PubMed ID: 19440163
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.